Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Repaglinid, ATC A10BX02

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jan 03, 2028 · 503 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Repaglinid, ATC A10BX02

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

No estimated value or guaranteed volume. Revenues depend on actual prescriptions and market share.

Contracts are automatically terminated if a competitive discount contract for Repaglinide is concluded by AOK Bayern or...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Feb 2028
  • Provision of the pharmaceutical product Repaglinide (ATC A10BX02) under non-exclusive discount agreements with AOK Bayern.
  • Contracts are identical and non-negotiable for all participating pharmaceutical companies.
Show full summary

This is an open-house model (not a standard procurement) by AOK Bayern for non-exclusive discount agreements on the active substance Repaglinide (ATC A10BX02). All interested pharmaceutical companies that meet the eligibility criteria can enter into identical, non-negotiable contracts. The contract runs from 01.03.2026 to 29.02.2028, with possible termination on one month's notice. No estimated value is provided. The procedure is open to all, with no competitive award criteria. Documentation is available online via DTVP portal.

Risks

No estimated value or guaranteed volume. Revenues depend on actual prescriptions and market share.

Contracts are automatically terminated if a competitive discount contract for Repaglinide is concluded by AOK Bayern or...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible.
  • Eligibility is demonstrated by a signed declaration of reliability.

Administrative

  • Contract must be submitted in two original copies (if paper) or with qualified electronic signature (if electronic).

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Repaglinid, ATC A10BX02

Non-exclusive discount agreements for Repaglinide (ATC A10BX02). Contract duration 01.03.2026 - 29.02.2028. Contracts can be concluded any time until 03.01.2028. Submission deadlines: 3rd of each month for start next month, or 10th for paper originals.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Feb 2026 - Feb 2028

Category

Pharmaceutical products

Deadline

Deadline Jan 03, 2028

Procurement Details

Publication date
13 Jan 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
26721-2026

Documents (2)

Similar tenders